182634-34-0

Basic information

• Product Name: BENZO[1,3]DIOXOL-4-METHYLAMINE
• Synonyms: BENZO[1,3]DIOXOL-4-METHYLAMINE;1,3-Benzodioxole-4-methanamine;benzo[d][1,3]dioxol-4-ylmethanamine;2,3-(Methylenedioxy)benzylaMine;2H-1,3-Benzodioxol-4-ylMethanaMine
• CAS NO: 182634-34-0
• Molecular Formula: C₈H₉NO₂
• Molecular Weight: 151.16
• EINECS: 604-604-1
• Mol File: 182634-34-0.mol

Chemical Properties

• Boiling Point: 85 °C(Press: 0.4 Torr)
• Appearance: /
• Density: 1.253±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C(protect from light)
• PKA: 9.16±0.29(Predicted)
• CAS DataBase Reference: BENZO[1,3]DIOXOL-4-METHYLAMINE(CAS DataBase Reference)
• NIST Chemistry Reference: BENZO[1,3]DIOXOL-4-METHYLAMINE(182634-34-0)
• EPA Substance Registry System: BENZO[1,3]DIOXOL-4-METHYLAMINE(182634-34-0)

Safety Data

• Hazardous Substances Data: 182634-34-0(Hazardous Substances Data)

Usage

Uses

Used in Chemical Research:
BENZO[1,3]DIOXOL-4-METHYLAMINE is used as a research compound for [application reason] in the field of chemical research. Its unique structure and properties make it a valuable subject for scientific investigation and potential applications in various chemical processes.
Used in Industrial Applications:
BENZO[1,3]DIOXOL-4-METHYLAMINE is used as an industrial chemical for [application reason] in various industries. Its versatility and reactivity in chemical reactions contribute to its utility in the development of new materials and products.

Upstream product

• 7797-83-3 2H-benzo[d]1,3-dioxolane-4-carbaldehyde 
• 24677-78-9 2,3-dihydroxybenzaldehyde 

Downstream Products

• 908274-59-9 2-methyl-2',3'-(methylenedioxy)dibenzylamine 
• 908274-58-8 2,3-(methylenedioxy)-3'-nitrodibenzylamine 

Relevant articles and documents

Modulators of protease activated receptors

The present invention provides novel compounds of the Formula (I), pharmaceutical compositions comprising such compounds and methods for using such compounds as tools for biological studies or as agents or drugs for therapies such as metabolic syndrome, obesity, type II diabetes, fibrosis and cardiovascular diseases, whether they are used alone or in combination with other treatment modalities.

ARYL FLUOROETHYL UREAS ACTING AS ALPHA 2 ADRENERGIC AGENTS

The invention provides well-defined aryl fluoroethyl ureas that are useful as selective alpha2 adrenergic agonists. As such, the compounds described herein are useful in treating a wide variety of disorders associated with modulation of alpha2 adrenergic receptors.

Pd(OAc)2-catalyzed carbonylation of amines

A phosphine-free catalytic system [Pd(OAc)2-Cu(OAc) 2-air] induced a substrate-specific carbonylation of amines in boiling toluene under CO gas (1 atm). Symmetrical N,N′-dialkylureas were obtained by the carbonylation of primary amines. N,N,N′-Trialkylureas were selectively formed by addition of a secondary amine to the above reaction vessel. Secondary amines did not give tetraalkylureas. However, dialkylamines with a phenyl group on their alkyl chains, such as N-monoalkylated benzylic amine or phenethylamine derivatives, underwent a direct aromatic carbonylation to afford five- or six-membered benzolactams. In the carbonylation, the chelation effect or steric repulsion between Pd(II) and the meta-substituent in the ortho-palladation and the ring sizes of cyclopalladation products that were formed prior to carbonylation were found to generate good site selectivity and increase the reaction rate. In contrast, carbonylation of ω- arylalkylamines with a hydroxyl group gave neither ureas nor benzolactams but instead produced 1,3-oxazolidinones smoothly. Hydrochlorides of amines also underwent carbonylation to afford the corresponding amides under the conditions used. This procedure made it possible to prepare ureas of amino acid esters and N-alkylcarbamates in practical yields.

Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof

The present invention relates to the discovery that certain non-naturally occurring, non-peptide amide compounds and amide derivatives, such as oxalamides, ureas, and acrylamides, are useful flavor or taste modifiers, such as a flavoring or flavoring agents and flavor or taste enhancer, more particularly, savory (the “umami” taste of monosodium glutamate) or sweet taste modifiers,—savory or sweet flavoring agents and savory or sweet flavor enhancers, for food, beverages, and other comestible or orally administered medicinal products or compositions.